Cargando…

Preclinical pharmacodynamic evaluation of antibiotic nitroxoline for anticancer drug repurposing

The established urinary antibiotic nitroxoline has recently regained considerable attention, due to its potent activities in inhibiting angiogenesis, inducing apoptosis and blocking cancer cell invasion. These features make nitroxoline an excellent candidate for anticancer drug repurposing. To rapid...

Descripción completa

Detalles Bibliográficos
Autores principales:	ZHANG, QI, WANG, SHANSHAN, YANG, DEXUAN, PAN, KEVIN, LI, LINNA, YUAN, SHOUJUN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841112/ https://www.ncbi.nlm.nih.gov/pubmed/27123101 http://dx.doi.org/10.3892/ol.2016.4380

Ejemplares similares

Rationally repurposed nitroxoline inhibits preclinical models of Epstein–Barr virus-associated lymphoproliferation
por: Ibáñez de Garayo, Maite, et al.
Publicado: (2021)

Repurposing of Nitroxoline as an Alternative Primary Amoebic Meningoencephalitis Treatment
por: Chao-Pellicer, Javier, et al.
Publicado: (2023)

Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells
por: Veschi, Serena, et al.
Publicado: (2018)

Susceptibility of Aerococcus urinae and Aerococcus sanguinicola to Standard Antibiotics and to Nitroxoline
por: Ahmadzada, Aysel, et al.
Publicado: (2023)

Chelation in Antibacterial Drugs: From Nitroxoline to Cefiderocol and Beyond
por: Repac Antić, Davorka, et al.
Publicado: (2022)

Integrative proteomic and functional analyses provide novel insights into the action of the repurposed drug candidate nitroxoline in AsPC-1 cells
por: Veschi, Serena, et al.
Publicado: (2020)

In vitro Activity of Repurposed Nitroxoline Against Clinically Isolated Mycobacteria Including Multidrug-Resistant Mycobacterium tuberculosis
por: Hoffmann, Ada Marie, et al.
Publicado: (2022)

Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer – a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation
por: Chang, Wei-Ling, et al.
Publicado: (2015)

The wisdom of crowds and the repurposing of artesunate as an anticancer drug
por: Augustin, Yolanda, et al.
Publicado: (2015)

Novel proapoptotic agent SM-1 enhances the inhibitory effect of 5-fluorouracil on colorectal cancer cells in vitro and in vivo
por: Wang, Ying, et al.
Publicado: (2017)

Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells
por: Chan-on, Waraporn, et al.
Publicado: (2015)

Antimicrobial activity of clioquinol and nitroxoline: a scoping review
por: Wykowski, Rachel, et al.
Publicado: (2022)

Repurposing anticancer drugs for the management of COVID-19
por: El Bairi, Khalid, et al.
Publicado: (2020)

Fruit fly for anticancer drug discovery and repurposing
por: Nainu, Firzan, et al.
Publicado: (2023)

In vitro activity of mecillinam, temocillin and nitroxoline against MDR Enterobacterales
por: Plambeck, Lars, et al.
Publicado: (2022)

Successful Treatment of Balamuthia mandrillaris Granulomatous Amebic Encephalitis with Nitroxoline
por: Spottiswoode, Natasha, et al.
Publicado: (2023)

Synthesis and evaluation of a large library of nitroxoline derivatives as pancreatic cancer antiproliferative agents
por: Veschi, Serena, et al.
Publicado: (2020)

P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma
por: Lohmann, Mia, et al.
Publicado: (2022)

Penfluridol as a Candidate of Drug Repurposing for Anticancer Agent
por: Tuan, Nguyen Minh, et al.
Publicado: (2019)

Nitroxoline: a potent antimicrobial agent against multidrug resistant Enterobacteriaceae
por: Cherdtrakulkiat, Rungrot, et al.
Publicado: (2019)

Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer
por: Lin, Wenfeng, et al.
Publicado: (2021)

Pharmacodynamics and Systems Pharmacology Approaches to Repurposing Drugs in the Wake of Global Health Burden
por: Bai, Jane P.F.
Publicado: (2016)

Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19
por: Baalbaki, Nadia, et al.
Publicado: (2023)

A Macromolecule Reversing Antibiotic Resistance Phenotype and Repurposing Drugs as Potent Antibiotics
por: Ding, Xin, et al.
Publicado: (2020)

Preclinical pharmacodynamic evaluation of drug candidate SKLB-178 in the treatment of non-small cell lung cancer
por: Zhong, Lei, et al.
Publicado: (2017)

Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activity
por: Mirković, Bojana, et al.
Publicado: (2015)

Drug repurposing against COVID-19: focus on anticancer agents
por: Ciliberto, Gennaro, et al.
Publicado: (2020)

Anticancer drugs repurposed for Alzheimer’s disease: a systematic review
por: Ancidoni, Antonio, et al.
Publicado: (2021)

Exploration of the Protection of Riboflavin Laurate on Oral Mucositis Induced by Chemotherapy or Radiotherapy at the Cellular Level: What Is the Leading Contributor?
por: Xuan, Zixue, et al.
Publicado: (2013)

Development and evaluation of a novel series of Nitroxoline-derived BET inhibitors with antitumor activity in renal cell carcinoma
por: Chen, Wei, et al.
Publicado: (2018)

Cathepsin inhibitors nitroxoline and its derivatives inhibit SARS-CoV-2 infection
por: Milan Bonotto, Rafaela, et al.
Publicado: (2023)

Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
por: Cowan, Noemi, et al.
Publicado: (2015)

Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge?
por: Ma, Zhaowu, et al.
Publicado: (2021)

Ethacrynic Acid: A Promising Candidate for Drug Repurposing as an Anticancer Agent
por: Yu, Lu, et al.
Publicado: (2023)

Enhancing the anticancer immune response with the assistance of drug repurposing and delivery systems
por: Fu, Zile, et al.
Publicado: (2023)

Repurposing Tranexamic Acid as an Anticancer Agent
por: Law, Mary E., et al.
Publicado: (2022)

Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates
por: De Lellis, Laura, et al.
Publicado: (2021)

Revisiting promising preclinical intracerebral hemorrhage studies to highlight repurposable drugs for translation
por: Crilly, Siobhan, et al.
Publicado: (2020)

Micheliolide Derivative DMAMCL Inhibits Glioma Cell Growth In Vitro and In Vivo
por: An, Yinghong, et al.
Publicado: (2015)

Cannabinoids as anticancer drugs: current status of preclinical research
por: Hinz, Burkhard, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oupf18p2gdu0fmo5pbbjsod5q6